Published in Gene Therapy Weekly, July 6th, 2006
Study 1: According to research from Singapore, embryonic stem (ES) cell pluripotency is regulated by Oct4 and Nanog transcription networks.
"Oct4 and Nanog are transcription factors required to maintain the pluripotency and self-renewal of ES cells," wrote Y.H. Loh and colleagues, Genome Institute of Singapore.
"Using the chromatin immunoprecipitation paired-end ditags method, we mapped the binding sites of these factors in the mouse ES cell genome. We identified 1,083 and 3,006 high-confidence binding sites for Oct4 and Nanog, respectively....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-07-06)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.